Document Detail


Effects of age and gender on the pharmacodynamics of omapatrilat in healthy volunteers.
MedLine Citation:
PMID:  11413936     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Omapatrilat is the most clinically advanced member of a new class of cardiovascular drugs, vasopeptidase inhibitors. Omapatrilat is a single molecule that simultaneously inhibits neutral endopeptidase and angiotensin-converting enzyme, thus preserving vasodilator peptides and inhibiting production of the vasoconstrictor angiotensin II. In healthy male volunteers, omapatrilat decreased blood pressure while being generally well tolerated, with no serious adverse events. This study was undertaken to determine the effect of age and gender on the pharmacodynamics of omapatrilat. Healthy male or female volunteers between the ages of 18 and 80 were given a single oral dose of omapatrilat 40 mg. Neither age nor gender affected the vasopeptidase inhibition by omapatrilat. There were no differences between subject groups in the effect of omapatrilat on supine systolic, diastolic, or mean arterial blood pressure. Based on this study of healthy subjects, it can be concluded that it is not necessary to adjust the initial dose of omapatrilat for the treatment of hypertension based solely on age or gender.
Authors:
W Liao; O Vesterqvist; J Manning; J L Hammett; I M Ferreira; A Meier; K D Davis; H W Hutman
Related Documents :
2256496 - Maternal and uteroplacental hemodynamic effects of chronic captopril in the hypertensiv...
3330936 - Autoregulation of glomerular blood flow during converting-enzyme inhibition by captopril.
16735936 - Effect of estrogen and angiotensin-converting enzyme inhibitor on vascular remodeling i...
17158556 - Intracystic pressure in patients with temporal arachnoid cysts: a prospective study of ...
10804896 - Do pressure relief cushions really relieve pressure?
3739586 - Severe acute propoxyphene overdose: plasma concentrations of propoxyphene and norpropox...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of geriatric cardiology     Volume:  10     ISSN:  1076-7460     ISO Abbreviation:  Am J Geriatr Cardiol     Publication Date:    2001 Jan-Feb
Date Detail:
Created Date:  2001-06-20     Completed Date:  2001-07-12     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9215283     Medline TA:  Am J Geriatr Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  50-4     Citation Subset:  IM    
Affiliation:
Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, NJ 08543-4000, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Aging / blood*
Cardiovascular Agents / pharmacokinetics*
Female
Humans
Male
Metabolic Clearance Rate
Middle Aged
Pyridines / pharmacokinetics*
Reference Values
Sex Factors
Thiazepines / pharmacokinetics*
Chemical
Reg. No./Substance:
0/Cardiovascular Agents; 0/Pyridines; 0/Thiazepines; 0/omapatrilat

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficacy and safety of angiotensin II receptor blockers in elderly patients with mild to moderate hy...
Next Document:  Men's reproductive and sexual health.